Read-Gene (Poland)

Recent papers from Read-Gene (Poland)

1. PCSK9 rs562556 variant and survival in BRCA1 mutation carriers and mutation-negative familial breast cancernpj Breast Cancer · 2026
2. All-Cause Mortality and Cancer Risk Dependent on Blood Se Level and HRG rs10770 Genotypes on a Prospective Cohort of Women with Familial Breast CancersInternational Journal of Molecular Sciences · 2026
3. Epigenetic and Liquid Biopsy Biomarkers in Prostate Cancer: Bridging Tumor Heterogeneity and Clinical ImplementationCancers · 2026
4. Primary and metastatic brain tumours in hereditary cancer syndromes: case reports with and literature reviewSHILAP Revista de lepidopterología · 2026
5. Ultra-Trace Blood Concentrations of Blood Serum Arsenic and Breast, Prostate and Colorectal Cancer Risks in the EPIC-Heidelberg CohortCancers · 2026
6. Serum Iodine Levels and 8-Year Survival in Patients After Kidney Cancer DiagnosisCancers · 2025
7. Blood Lead (Pb) Levels as a Possible Marker of Cancer Risk in a Prospective Cohort of Women with Non-Occupational ExposureBiomedicines · 2025
8. Synergic effect of arsenic exposure related methylation changes in three cohorts exposed to levels of this toxicantInternational Archives of Occupational and Environmental Health · 2025
9. Blood and Serum Copper and Zinc Levels and 10-Year Survival of Patients After Kidney Cancer DiagnosisNutrients · 2025
10. The Effect of Blood Selenium Level on the pCR Rate in Breast Cancer Patient Receiving Neoadjuvant ChemotherapyCancers · 2025
11. Blood molybdenum level as a marker of cancer risk on BRCA1 carriersHereditary Cancer in Clinical Practice · 2024
12. Pro/antioxidant status and selenium, zinc and arsenic concentration in patients with bipolar disorder treated with lithium and valproic acidFrontiers in Molecular Neuroscience · 2024
13. Blood and Serum Se and Zn Levels and 10-Year Survival of Patients after a Diagnosis of Kidney CancerBiomedicines · 2024
14. Cobalt Serum Level as a Biomarker of Cause-Specific Survival among Prostate Cancer PatientsCancers · 2024
15. Antioxidant Properties of Zinc and Copper—Blood Zinc-to Copper-Ratio as a Marker of Cancer Risk BRCA1 Mutation CarriersAntioxidants · 2024
16. Blood Iodine as a Potential Marker of the Risk of Cancer in BRCA1 CarriersNutrients · 2024
17. Blood molybdenum level as a marker of cancer risk among BRCA1 carriers2024
18. Zinc and Its Antioxidant Properties: The Potential Use of Blood Zinc Levels as a Marker of Cancer Risk in BRCA1 Mutation CarriersAntioxidants · 2024
19. Selenium and Arsenic Levels, Prevalence of Common Variants of Genes Involved in Their Metabolism, and Psoriasis DiseaseBiomedicines · 2024
20. Blood Lead Level as Marker of Increased Risk of Ovarian Cancer in BRCA1 CarriersNutrients · 2024